Drug Shortage Report for ELOCTATE
Report ID | 171705 |
Drug Identification Number | 02430355 |
Brand name | ELOCTATE |
Common or Proper name | ELOCTATE 3000 |
Company Name | SANOFI-AVENTIS CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ANTIHEMOPHILIC FACTOR |
Strength(s) | 3000UNIT |
Dosage form(s) | POWDER FOR SOLUTION KIT |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 3000 IU/vial |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-10-12 |
Estimated end date | 2022-12-02 |
Actual end date | 2022-12-05 |
Shortage status | Resolved |
Updated date | 2022-12-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-10-13 | English | Compare |
v2 | 2022-10-13 | French | Compare |
v3 | 2022-11-30 | English | Compare |
v4 | 2022-11-30 | French | Compare |
v5 | 2022-12-05 | English | Compare |
v6 | 2022-12-05 | French | Compare |
v7 | 2022-12-06 | English | Compare |
Showing 1 to 7 of 7